First cannabis-based medicine approved by FDA arrives in the U.S.
Epidiolex, made with cannabidiol, is to be used to treat two types of epilepsy
For the first time, a marijuana-based medicine approved by federal regulators is available for prescription in the United States.
The medicine, called Epidiolex, is used to treat seizures related to Lennox-Gastaut and Dravet syndromes, two forms of epilepsy, which is a neurological disorder, according to a news release.
“Because these patients have historically not responded well to available seizure medications, there has been a dire need for new therapies that aim to reduce the frequency and impact of seizures,” said Justin Gover, chief executive officer of GW Pharmaceuticals, the United Kingdom-based company that developed the drug, in a statement.
The oral medication was approved by the U.S. Food and Drug Administration in June. It is made using plant-derived cannabidiol, which lacks the high associated with marijuana.
Epidiolex, when added to other anti-epileptic treatments, reduced the frequency of seizures in patients during clinical trials, according to GW Pharmaceuticals.
Support Local Journalism
Support Local Journalism
As a Summit Daily News reader, you make our work possible.
Summit Daily is embarking on a multiyear project to digitize its archives going back to 1989 and make them available to the public in partnership with the Colorado Historic Newspapers Collection. The full project is expected to cost about $165,000. All donations made in 2023 will go directly toward this project.
Every contribution, no matter the size, will make a difference.